New model could predict lymphoma progression two years early

NCT ID NCT03436602

Ongoing Knowledge-focused Sponsor: Oncology Institute of Southern Switzerland Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 20 times

Summary

This study aims to create a model that combines clinical and genetic information to better predict which follicular lymphoma patients will remain cancer-free for at least two years after their first treatment. Researchers will analyze data from 370 patients to improve risk assessment. The goal is to help doctors personalize care and identify patients who may need closer monitoring.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department

Reggio Emilia, RE, 42123, Italy
Azienda Ospedaliera Universitaria Maggiore della Carità

Novara, 28100, Italy
Institute of Oncology Research

Bellinzona, Canton Ticino, 6500, Switzerland
Institute of Pathology

Locarno, Canton Ticino, Switzerland

Conditions

Explore the condition pages connected to this study.

FOLLICULAR LYMPHOMA